Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Counting Market

Cell Counting Market Trends

Report ID: GMI8496
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Cell Counting Market Trends

The increased focus on exploring regenerative medicine, immunotherapy, and cell-based therapies for diverse diseases has reinforced the demand for precise cell-counting tools, thereby augmenting the market growth.
Also, rising research funding for cell-based therapeutics further fuels expansion in the cell counting industry. For instance, in March 2023, the Stem Cell Research and Eli and Edythe Broad Center of Regenerative Medicine at UCLA secured over USD 5.7 million in funding from the California Institute for Regenerative Medicine. This funding aimed to bolster stem cell-based technologies for treating cancer and intellectual disabilities. Thus, accurate cell counting is crucial for assessing cell viability, proliferation, and dosage, playing a pivotal role in advancing R&D in this domain and consequently facilitating market expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cell counting reached USD 11.7 billion in 2023 and is set to expand at 6.6% CAGR over 2024-2032, led by the rising incidence of chronic diseases such as HIV, measles, diphtheria, cancer, and blood disorders.

The consumables and reagents segment is slated to depict substantial growth at 6.7% CAGR from 2024 to 2032, as they are essential in facilitating accurate and efficient cell counting processes.

North America accounted for 38% of the market share in 2023, attributed to a larger patient population, increased adoption of high-throughput flow cytometry and automated hematology analyzers in healthcare settings in the region.

Prominent cell counting companies include Abbott Laboratories, Agilent Technologies, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biote, Instruments, Inc., ChemoMetec A/S, DeNovix, Merck KGaA, NanoEnTek Inc, Olympus Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc.